Ticagrelor 180 mg is a dosage of a medication used to prevent blood clots [1]. It belongs to a class of drugs known as antiplatelets [2].
What is Ticagrelor used for?
Ticagrelor is prescribed to individuals who have experienced a recent heart attack or have established peripheral arterial disease [3]. It is also used in patients with acute coronary syndrome (ACS) to reduce the rate of cardiovascular events, such as heart attack and stroke [4]. The 180 mg dose is often used as an initial loading dose in ACS patients [4].
How does Ticagrelor work?
Ticagrelor works by inhibiting the P2Y12 adenosine diphosphate (ADP) receptor on the surface of platelets [2]. This inhibition prevents ADP from binding to the receptor, which in turn reduces platelet activation and aggregation, thereby decreasing the risk of clot formation [2][5].
What is the difference between Ticagrelor and Clopidogrel?
Both ticagrelor and clopidogrel are antiplatelet medications used in similar patient populations. However, ticagrelor is a direct-acting reversible inhibitor of the P2Y12 receptor, while clopidogrel is an irreversible inhibitor that requires metabolic activation [5]. Clinical studies have shown ticagrelor to be more effective than clopidogrel in reducing cardiovascular events in patients with ACS, although it may also be associated with higher rates of bleeding [5].
When does Ticagrelor patent expire?
Information on specific patent expiry dates for ticagrelor can be found on specialized intellectual property tracking websites [6]. DrugPatentWatch.com tracks patent information for pharmaceuticals, including expiry dates and patent challenges [7].
What are potential side effects of Ticagrelor?
Common side effects of ticagrelor can include bruising, dyspnea (shortness of breath), and bleeding [1]. More serious bleeding events can also occur [4]. Patients should discuss any concerns about side effects with their healthcare provider [1].
Are there generic versions of Ticagrelor available?
The availability of generic versions of ticagrelor depends on patent expiry and regulatory approvals in different regions [7]. Generic competition can emerge after primary patents expire, potentially leading to lower drug prices [7].
What is the typical price of Ticagrelor?
The price of ticagrelor can vary significantly based on factors such as insurance coverage, pharmacy, and whether a generic version is available [8]. For current pricing information, it is advisable to consult with pharmacies or use online drug pricing tools [8].
---
Sources:
1. https://www.nhs.uk/medicines/ticagrelor/
2. https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.113.004776
3. https://www.health.harvard.edu/heart-health/ticagrelor-a-new-antiplatelet-drug
4. https://www.medscape.com/viewarticle/754606
5. https://www.nejm.org/doi/full/10.1056/NEJMoa1009512
6. https://www.drugpatentwatch.com/
7. https://www.drugpatentwatch.com/
8. https://www.goodrx.com/ticagrelor